Karyopharm Therapeutics
KPTI
KPTI
85 hedge funds and large institutions have $636M invested in Karyopharm Therapeutics in 2015 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 49 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
39% less call options, than puts
Call options by funds: $2.76M | Put options by funds: $4.52M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
85
Holding in Top 10
1
Calls
$2.76M
Puts
$4.52M
Top Buyers
| 1 | +$29.1M | |
| 2 | +$10.4M | |
| 3 | +$9.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.4M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$8.38M |
Top Sellers
| 1 | -$37.4M | |
| 2 | -$10.1M | |
| 3 | -$7.86M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.03M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.98M |